Sir, I turned much darker!
Zenz
Thorsten
T
Department of Internal Medicine III, University of Ulm, Ulm, Germany.
Aufschild
Julia
J
Boehm
Bernhard O
BO
D000224:Addison Disease / Q000175:diagnosis* / Q000209:etiology* / Q000473:pathology; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004977:Ethambutol / Q000627:therapeutic use; D005858:Germany; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D017495:Hyperpigmentation / Q000473:pathology*; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014383:Tuberculosis, Endocrine / Q000150:complications* / Q000188:drug therapy*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D006854:Hydrocortisone